Phase 3 trials for Retatrutide are currently enrolling participants across North America, including sites in Canada
Your provider connects the dotsmeds, lifestyle, and root causes
News &World Report magazines annual Best Childrens Hospitals rankings, now in its ninth year
Head-to-head clinical evidence SURPASS-2: Mounjaro vs Ozempic in type 2 diabetes The SURPASS-2 trial, published in the New England Journal of Medicine, directly compared tirzepatide with semaglutide 1 mg (the standard Ozempic dose) in 1,879 people with type 2 diabetes over 40 weeks
While no provider is completely immune to supply disruptions, the compounded pathway has historically offered more reliable access during periods of brand-name shortage
Malignant tumors on the muscles and lymph nodes can cause edema